Here are the 25 drugs most often administered in outpatient settings, followed by percentage of outpatient encounters:
- Triamcinolone acetonide, injection, 10mg: 12.3 percent
- Dexamethasone sodium phosphate, injection, 1mg: 8.1 percent
- Vitamin B-12 injection, 1,000mcg: 4.2 percent
- Ketorolac tromethamine, injection, 15mg: 3.8 percent
- Alfibercept, injection, 1mg: 3.7 percent
- Betamethasone acetate and betamethasone sodium phosphate, injection, 3 mg: 3.4 percent
- Ceftriaxone sodium, injection, 250mg: 3.2 percent
- Methylprednisolone acetate, injection, 40mg: 3.2 percent
- Bevacizumab, injection, 10mg: 2.9 percent
- Unclassified drugs, injection: 2.4 percent
- Testosterone cypionate, injection, 1mg: 2.2 percent
- Methylprednisolone acetate, injection, 80mg: 2.1 percent
- Medroxyprogesterone acetate, injection, 1mg: 1.7 percent
- Diphenhydramine HCL, injection, 50mg: 1.6 percent
- Regadenoson, injection, 0.1mg: 1.6 percent
- OnabotulinumtoxinA, injection, 1 unit: 1.5 percent
- Normal saline solution, infusion, 1,000cc: 1.4 percent
- Normal saline solution, infusion, 250cc: 1.1 percent
- Ondansetron hydrochloride, per 1mg: 1.1 percent
- Denosumab, injection, 1mg: 1.1 percent
- Palonosetron HCL, injection, 25mcg: 1 percent
- Iron sucrose, injection, 1mg: 1 percent
- Methylprednisolone sodium succinate, injection, 125mg: 0.9 percent
- Ranibizumab, injection, 0.1mg: 0.8 percent
- Omalizumab, injection, 5mg: 0.8 percent
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
